|
1
|
Beatson GT: On the treatment of inoperable
cases of carcinoma of the mamma: suggestions for a new method of
treatment, with illustrative cases. Lancet. 2:104–107. 1986.
|
|
2
|
Altieri A, Tavani A, Gallus S, Bosetti C,
Talamini R, Franceschi S, Levi F and La Vecchia C: Correspondence
re: Simon et al.Do thyroid disorders increase the risk of breast
cancer? Cancer Epidemiol Biomarkers Prev. 12:684–686.
2003.PubMed/NCBI
|
|
3
|
Ito K and Maruchi N: Breast cancer in
patients with Hashimoto's thyroiditis. Lancet. 2:1119–1121. 1975.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rasmusson B, Feldt-Rasmussen U, Hegedüs L,
Perrild H, Bech K and Høier-Madsen M: Thyroid function in patients
with breast cancer. Eur J Cancer Clin Oncol. 23:553–556. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shering SG, Zbar AP, Moriarty M, McDermott
EW, O'Higgins NJ and Smyth PP: Thyroid disorders and breast cancer.
Eur J Cancer Prev. 5:504–506. 1996.PubMed/NCBI
|
|
6
|
Maruchi N, Annegers JF and Kurland LT:
Hashimoto's thyroiditis and breast cancer. Mayo Clin Proc.
51:263–265. 1976.PubMed/NCBI
|
|
7
|
Anker GB, Lønning PE, Aakvaag A and Lien
EA: Thyroid function in postmenopausal breast cancer patients
treated with tamoxifen. Scand J Clin Lab Invest. 58:103–107. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kurland LT and Annegers JF: Letter: Breast
cancer and Hashimoto's thyroiditis. Lancet. 1:8081976. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nogueira CR and Brentani MM:
Triiodothyronine mimics the effect of estrogen in breast cancer
cell lines. J Steroid Biochem Mol Biol. 59:271–279. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dinda S, Sanchez A and Moudgil V:
Estrogen-like effects of thyroid hormone on the regulation of tumor
suppressor proteins, p53 and retinoblastoma, in breast cancer
cells. Oncogene. 21:761–768. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vonderhaar BK and Greco AE:
Lobulo-alveolar development of mouse mammary glands is regulated by
thyroid hormones. Endocrinology. 104:409–418. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mittra I, Perrin J and Kumaoka S: Thyroid
and other autoantibodies in British and Japanese women: an
epidemiological study of breast cancer. Br Med J. 1:257–259. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zophel K, Roggenbuck D and Schott M:
Clinical review about TRAb assay's history. Autoimmun Rev.
9:695–700. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McLachlan SM and Rapoport B: The molecular
biology of thyroid peroxidase: cloning, expression, and role as
autoantigen in autoimmune thyroid disease. Endocr Rev. 13:192–206.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khoury EL, Hammond L, Bottazzo GF and
Doniach D: Presence of the organ-specific ‘microsomal’ autoantigen
on the surface of human thyroid cells in culture: its involvement
in complement-mediated cytotoxicity. Clin Exp Immunol. 45:316–328.
1981.PubMed/NCBI
|
|
16
|
Mariotti S, Caturegli P, Piccolo P,
Barbesino G and Pinchera A: Antithyroid peroxidase autoantibodies
in thyroid diseases. J Clin Endocrinol Metab. 71:661–669. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feldt-Rasmussen U, Høier-Madsen M, Bech K,
et al: Anti-thyroid peroxidase antibodies in thyroid disorders and
non-thyroid autoimmune diseases. Autoimmunity. 9:245–254. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gogas J, Kouskos E, Tseleni-Balafouta S,
Markopoulos C, Revenas K, Gogas G and Kostakis A: Autoimmune
thyroid disease in women with breast carcinoma. Eur J Surg Oncol.
27:626–630. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Myhill J, Reeve TS and Hales IB: Thyroid
function in breast cancer. Acta Endocrinol (Copenh). 51:290–300.
1996.
|
|
20
|
Giani C, Fierabracci P, Bonnaci R, et al:
Relationship between breast cancer and thyroid disease: relevance
of autoimmune thyroid disorders in breast malignancy. J Clin
Endocrinol Metab. 81:990–994. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smyth PP: Autoimmune thyroid disease and
breast cancer: a chance association? J Endocrinol Invest. 23:42–43.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sarlis NJ, Gourgiotis L, Pucino F and
Tolis GJ: Lack of association between Hashimoto thyroiditis and
breast cancer: a quantitative research synthesis. Hormones
(Athens). 1:35–41. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simon MS, Tang MT, Bernstein L, et al: Do
thyroid disorders increase the risk of breast cancer? Cancer
Epidemiol Biomarkers Prev. 11:1574–1578. 2002.PubMed/NCBI
|
|
24
|
Cristofanilli M, Yamamura Y, Kau SW, et
al: Thyroid hormone and breast carcinoma. Primary hypothyroidism is
associated with a reduced incidence of primary breast carcinoma.
Cancer. 103:1122–1128. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Farahati J, Roggenbuck D, Gilman E,
Schütte M, Jagminaite E, Seyed Zakavi R, Löning T and Heissen E:
Anti-thyroid peroxidase antibodies are associated with the absence
of distant metastases in patients with newly diagnosed breast
cancer. Clin Chem Lab Med. 50:709–714. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prinzi N, Baldini E, Sorrenti S, et al:
Prevalence of breast cancer in thyroid diseases: results of a
cross-sectional study of 3,921 patients. Breast Cancer Res Treat.
144:683–688. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rodien PM, Madec AM, Ruf J, et al:
Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid
disease: relationship to antithyroperoxidase antibodies. J Clin
Endocrinol Metab. 81:2595–2600. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bhattacharya A and Vonderhaar BK: Specific
binding proteins for 3, 5, 30-triiodothyronine in mouse mammary
epithelium. J Cell Biol. 75:47a1977.
|
|
29
|
Selliti DF, Tseng YC and Latham KR:
Nuclear thyroid hormone receptor in C3H/HeN mouse mammary glands
and spontaneous tumors. Cancer Res. 43:1030–1038. 1983.PubMed/NCBI
|
|
30
|
Smallridge RC and Latham KR: Nuclear
thyroid hormone receptor in human breast tumors. Clin Res.
28:4211980.
|
|
31
|
Cerbon MA, Pichon MF and Milgrom E:
Thyroid hormone receptors in human breast cancer. Cancer Res.
41:4167–4173. 1981.PubMed/NCBI
|
|
32
|
Spitzweg C, Joba W, Eisenmenger W and
Heufelder AE: Analysis of human sodium iodide symporter gene
expression in extrathyroidal tissues and cloning of its
complementary deoxyribonucleic acids from salivary gland, mammary
gland, and gastric mucosa. J Clin Endocrinol Metab. 83:1746–1751.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kilbane MT, Ajjan RA, Weetman AP, Dwyer R,
McDermott EW, O'Higgins NJ and Smyth PP: Tissue iodine content and
serum-mediated 125I uptake-blocking activity in breast cancer. J
Clin Endocrinol Metab. 85:1245–1250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stadel BV: Dietary iodine and risk of
breast, endometrial, and ovarian cancer. Lancet. 1:890–891. 1976.
View Article : Google Scholar : PubMed/NCBI
|
